Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

BACKGROUND: Colchicine has been proposed as a treatment for COVID-19 based on its anti-inflammatory actions. We aimed to evaluate the efficacy and safety of colchicine in patients admitted to hospital with COVID-19. METHODS: In this streamlined, randomised, controlled, open-label trial, underway at...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523117/
https://www.ncbi.nlm.nih.gov/pubmed/34672950
http://dx.doi.org/10.1016/S2213-2600(21)00435-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523117/
https://www.ncbi.nlm.nih.gov/pubmed/34672950
http://dx.doi.org/10.1016/S2213-2600(21)00435-5

Ejemplares similares